BackBioNTech SE Overview

BioNTech SE Goodwill

Latest goodwill for BNTX: $370M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$373.15M
↑ 2.48% YoYΔ $9.05M vs prior year quarter

Peer trimmed avg / median

Loading

BioNTech SE Goodwill History

Loading

BioNTech SE vs. peers: Goodwill Comparison

Loading

BioNTech SE Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioNTech SE (BNTX) FAQ

As of the most recent data (June 2026), BNTX shows a goodwill of $370M. That compares with $360M in the prior-year period — up 2.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BNTX's goodwill is now $370M (was $360M) — a 2.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BioNTech SE is outperforming or lagging.

Tracking BNTX's goodwill over time shows whether BioNTech SE is scaling, shrinking, or reshaping that part of the business. The current reading is $370M That compares with $360M in the prior-year period — up 2.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has BioNTech SE's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $370M) with ownership activity and broader fundamentals.

BioNTech SE's goodwill is $370M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.